Clinical trial
Efficacy, Safety and Acceptability of Ascending Doses of Ivermectin in Combination With Albendazole for Trichuris Trichiura Infections in Preschool-aged Children: a Single-blind Randomised Controlled Dose-ranging Trial
NCT06184399 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety and Acceptability of Ascending Doses of Ivermectin in Combination With Albendazole for Trichuris Trichiura Infections in Preschool-aged Children: a Single-blind Randomised Controlled Dose-ranging Trial
- Lead sponsor
- Jennifer Keiser
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 5, 2024
- Completion date
- August 9, 2024
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.